pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1179 |
Genomic Coordinates | chr15: 88608107 - 88608197 |
Synonyms | MIRN1179, hsa-mir-1179, MIR1179 |
Description | Homo sapiens miR-1179 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1179 | ||||||||||||||||||
Sequence | 15| AAGCAUUCUUUCAUUGGUUGG |35 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PCSK1 | ||||||||||||||||||||
Synonyms | BMIQ12, NEC1, PC1, PC3, SPC3 | ||||||||||||||||||||
Description | proprotein convertase subtilisin/kexin type 1 | ||||||||||||||||||||
Transcript | NM_000439 | ||||||||||||||||||||
Other Transcripts | NM_001177875 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PCSK1 | |||||||||||||||||||||
3'UTR of PCSK1 (miRNA target sites are highlighted) |
>PCSK1|NM_000439|3'UTR 1 AATAAGTGTGTGGTCCCAAGTTGGAAATATTCATGCTTCTTCCTTACCCTGCGATTTTGCCTGTGTCTGAAGTGGTTGTT 81 TTGTCATGAATTCTTATGCTTATAATATCCTTTGTGGCACCTTTTCTTTTTCTCCCTAAACTGTACATGTGAAGGGGATG 161 AGCTCAAGCAGGAAGTTCAACTTCCAGAATTGATCATAGGTATTTCAAAACACATCTTTCCTGTCTGCACAAGTGAAGTG 241 TTTTGTTCTTTCTGGAGTCACAGTTGACAAAAAGCTCTTACACTACATTAGAACACTGCATTAGAGCCCATTTCAATTCT 321 CAAAAGAAAAGGCAAAACCTGGGATATCAATTAATTTGAAAACATAATCTGCAAAGAATGAGAAGGAGTCAGAAACTGTT 401 TCTGTAGCTTGTTCCCTGTCTTGTCCATGTGGTTCTTCAAATTTTGATGCCAAGAAAGTATTTGGTAGGCCTAATGAAGG 481 AGTTCACTGTAAGACTCATTCCCTAGATCTTTCTATTCCAAAGTGCCACTCATTCCTGTAGTCAAAATCTGGTCATGTTG 561 GTCAAAAGCTGGATTATTTAGATCTAGAAACAGATCTTGAAATCTGAATGCTCTGGTTTGAGCAATTTTCGAACATTCTT 641 TGCCTGGTGCACTGTGTCTGTGGTGCCAGAGGCGTCCGTGGATCCAGAGGTGGTTATGACTCGTGCTGCATGCCTGGTCT 721 TTCCTCTGTTTCTCCTTCTGAAAGTTTTCTATACCTGTCTCCTTTCTCAGCCACAAAATAAATGTTGGGAGAAATGATAT 801 ATACCACTTTCCCAGAAAAAAAAAAACTTACACTTGGGACTTGGCAAATTCCTAGTCACAATTTTTTTCAGCAGTAACAG 881 GAAACCACTTATCACATGGAGACCTAATGTAATAATAGAAAAATACTCATAATAGGGAGAAACCAAGAGAAGTTTTGTTT 961 TTGTTTTTTTCCAACTGTGTTCATTAGAACAGCGTGTTCTAAGTATTTGAAACTGAATGTTTATTCCTTGATACTAAAAG 1041 TTCTTCTCCAATCCTATCACTGATAGTGTCCAAATTCTCACCAAATTGCTCCTAAGCTTCAAATCAGAAGCAGAAACTGG 1121 CAGGCCATGGACCTTAATTGTCCCTCAGGTAGATTTTGTTTGGTATGCAGAATGTTTTTAAAATATGAGTGGTTATTGAA 1201 AATATGATGTTTCACATAAAACCTCATTCTCGGACCCATCTTTGCTCATGGCAACAGTTAGCTGGAGCTGAGTAGCAGCT 1281 GCCTGATTAGATGACTCTCAGTCCCCATGGCACCCTGCTCCATGTTACCTAGAGCAGGCACTTGATTCCTTGCTGGGCAG 1361 TATCCAATAGGCATTTGATTTTGCCCACTCCTACACTAAGCGAATGTGTACAAAGTGTAAATGCATTAGGAAAAACAAAC 1441 TACCCGCATCTTCTGTTAGGCAGGATCTGTACAATAATAATTATGAGTTTGCTTATGTAATCTCACCTCACCTGGATGAT 1521 CACTAATACTAATTCATTTATTACTAACCTTCTGGCTTCCTTCTCTCAATATGCTTACAAAGTCTCCAGTCACCTACAAT 1601 GCTGGCTTTCTCCCACTGAGTTTGCTGTTTGCAATTTTTCCATGAAGTTTGAACTTCATAAGGTAATTCATGGCATTGAA 1681 CTGGTTCATGAAAAGAACACTAGAGTCTGTCATTTGCTTTGGCTTGAAGTATGGTTGGTAACACAAATTTTCACCTGCTC 1761 TTCTACCATTTGAATTTGTGTAGAGGGTGTTTGCAGAGCAATGCCCGTAATGCTTAGAGAATGTTCTCCTAAAAGACTTG 1841 CGGAATCACTCTGTCCTTGGAAGTTTCATATATTGTTTGATATGAAGTGTTAGATAGAATTTCCAATATTGGAGCATATC 1921 AAAAAGTATTAAAACTAAAAAGGACCAGAGAATTCTTAGATTGGCCCGGAAAGGCCAATAAAGAGTTAGAATGAAAACTC 2001 ATTACTTTTCCATTCCCAATCTAGTGCTAGATGTATAAATCTTTCTTTTGATTCTTCCTAACAAAATATTTTCTGGGTTA 2081 AAACCCCAGCCAACTCATTGGGTTGTAGCCAAAGGTTCACTCTCAAGAAGCTTTAATATTTAAATAAAATCATATTGAAT 2161 GTTTCCAACCTGGAGTATAATATTCAGATATAAAACAGTTTTGTCAGTCTTTCTTAGTGCCTGTGTGGATTTTTGTGAAA 2241 ATGTCAAAGAGAAAACTTATATACTATTTCCCTTGAAATTTTAAACTATATTTTCTTTACAGGTATTTATAATATACCAA 2321 TGCTTTTATCAAACAGAATTTTAAAGAGCATAATAAATTATATTAAAGAACCAAAAGTTTTCCTGAGAATAAGAAAGTTT 2401 CACCCAATAAAATATTTTTGAAAGGCATGTTCCTCTGTCAATGAAAAAAAGTACATGTATGTGTTGTGATATTAAAAGTG 2481 ACATTTGTCTAATAGCCTAATACAACATGTAGCTGAGTTTAACATGTGTGGTCTTGGTATTCTTAAGGGAACTTCCACAT 2561 TATACATTTGATGTATTGACCAGAATATGTAAAATATGCTTATAAATCAGAAAAATAAATTGTTTCTCACTAAGTCAAAA 2641 GAAAAAAAGCTCATGTTTCCACCAC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 5122.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_000439 | 3UTR | UUCCUGUAGUCAAAAUCUGGUCAUGUUGGUCAAAAGCUGGAUUAUUUAGAUCUAGAAACAGAUCUUGAAAUCUGAAUGCUCUGGUUUGAGCAAUUUUCGAACAUUCUUUGCCUGGUGCACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_000439 | 3UTR | AUUCCUGUAGUCAAAAUCUGGUCAUGUUGGUCAAAAGCUGGAUUAUUUAGAUCUAGAAACAGAUCUUGAAAUCUGAAUGCUCUGGUUUGAGCAAUUUUCGAACAUUCUUUGCCUGGUGCACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_000439 | 3UTR | CCUGUAGUCAAAAUCUGGUCAUGUUGGUCAAAAGCUGGAUUAUUUAGAUCUAGAAACAGAUCUUGAAAUCUGAAUGCUCUGGUUUGAGCAAUUUUCGAACAUUCUUUGCCUGGUGCACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_000439 | 3UTR | UCAUUCCUGUAGUCAAAAUCUGGUCAUGUUGGUCAAAAGCUGGAUUAUUUAGAUCUAGAAACAGAUCUUGAAAUCUGAAUGCUCUGGUUUGAGCAAUUUUCGAACAUUCUUUGCCUGGUGCACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_000439 | 3UTR | AGUCAAAAUCUGGUCAUGUUGGUCAAAAGCUGGAUUAUUUAGAUCUAGAAACAGAUCUUGAAAUCUGAAUGCUCUGGUUUGAGCAAUUUUCGAACAUUCUUUGCCUGGUGCACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_000439 | 3UTR | AAAUCUGGUCAUGUUGGUCAAAAGCUGGAUUAUUUAGAUCUAGAAACAGAUCUUGAAAUCUGAAUGCUCUGGUUUGAGCAAUUUUCGAACAUUCUUUGCCUGGUGCACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000311106.3 | 3UTR | GAAACAGAUCUUGAAAUCUGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
56 hsa-miR-1179 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT055796 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT165931 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT193416 | RORA | RAR related orphan receptor A | 2 | 4 | ||||||||
MIRT270559 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT379031 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT397265 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 2 | ||||||||
MIRT397728 | PAWR | pro-apoptotic WT1 regulator | 2 | 4 | ||||||||
MIRT442893 | MYNN | myoneurin | 2 | 2 | ||||||||
MIRT443223 | ARL5B | ADP ribosylation factor like GTPase 5B | 2 | 2 | ||||||||
MIRT455068 | ARHGAP39 | Rho GTPase activating protein 39 | 2 | 2 | ||||||||
MIRT457420 | CASC5 | kinetochore scaffold 1 | 2 | 2 | ||||||||
MIRT459303 | PHYKPL | 5-phosphohydroxy-L-lysine phospho-lyase | 2 | 2 | ||||||||
MIRT474139 | LIN54 | lin-54 DREAM MuvB core complex component | 2 | 4 | ||||||||
MIRT480804 | BLOC1S2 | biogenesis of lysosomal organelles complex 1 subunit 2 | 2 | 6 | ||||||||
MIRT483224 | ZWINT | ZW10 interacting kinetochore protein | 2 | 2 | ||||||||
MIRT494968 | USP46 | ubiquitin specific peptidase 46 | 2 | 2 | ||||||||
MIRT496531 | ID2 | inhibitor of DNA binding 2, HLH protein | 2 | 2 | ||||||||
MIRT497593 | SLC23A1 | solute carrier family 23 member 1 | 2 | 2 | ||||||||
MIRT500683 | TRIM37 | tripartite motif containing 37 | 2 | 2 | ||||||||
MIRT506538 | MORF4L1 | mortality factor 4 like 1 | 2 | 4 | ||||||||
MIRT514699 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT516421 | ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif 4 | 2 | 2 | ||||||||
MIRT516864 | TYW5 | tRNA-yW synthesizing protein 5 | 2 | 2 | ||||||||
MIRT521048 | SLC2A3 | solute carrier family 2 member 3 | 2 | 4 | ||||||||
MIRT523817 | FAM179A | TOG array regulator of axonemal microtubules 2 | 2 | 4 | ||||||||
MIRT528884 | ATF3 | activating transcription factor 3 | 2 | 2 | ||||||||
MIRT530375 | PCSK1 | proprotein convertase subtilisin/kexin type 1 | 2 | 2 | ||||||||
MIRT536813 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 2 | ||||||||
MIRT537030 | GRIN2B | glutamate ionotropic receptor NMDA type subunit 2B | 2 | 2 | ||||||||
MIRT537864 | EFNA5 | ephrin A5 | 2 | 2 | ||||||||
MIRT544600 | FOXO3 | forkhead box O3 | 2 | 4 | ||||||||
MIRT547016 | PPP1R12A | protein phosphatase 1 regulatory subunit 12A | 2 | 4 | ||||||||
MIRT551016 | DMPK | DM1 protein kinase | 2 | 9 | ||||||||
MIRT551306 | MARVELD2 | MARVEL domain containing 2 | 2 | 2 | ||||||||
MIRT556932 | IREB2 | iron responsive element binding protein 2 | 2 | 2 | ||||||||
MIRT562241 | HMGB1 | high mobility group box 1 | 5 | 2 | ||||||||
MIRT566610 | NR3C1 | nuclear receptor subfamily 3 group C member 1 | 2 | 2 | ||||||||
MIRT567498 | FOXJ3 | forkhead box J3 | 2 | 2 | ||||||||
MIRT573432 | ALDOA | aldolase, fructose-bisphosphate A | 2 | 2 | ||||||||
MIRT575921 | Dmpk | dystrophia myotonica-protein kinase | 2 | 6 | ||||||||
MIRT621349 | AADAC | arylacetamide deacetylase | 2 | 2 | ||||||||
MIRT623719 | HACE1 | HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT628303 | CREB5 | cAMP responsive element binding protein 5 | 2 | 2 | ||||||||
MIRT629775 | FAM57A | family with sequence similarity 57 member A | 2 | 2 | ||||||||
MIRT668030 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT668681 | DPH3 | diphthamide biosynthesis 3 | 2 | 2 | ||||||||
MIRT674268 | ZNF284 | zinc finger protein 284 | 2 | 2 | ||||||||
MIRT681490 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT699899 | RUNX1 | runt related transcription factor 1 | 2 | 2 | ||||||||
MIRT700856 | PERP | PERP, TP53 apoptosis effector | 2 | 2 | ||||||||
MIRT701079 | PARD6B | par-6 family cell polarity regulator beta | 2 | 2 | ||||||||
MIRT701503 | NEGR1 | neuronal growth regulator 1 | 2 | 2 | ||||||||
MIRT719117 | MAML1 | mastermind like transcriptional coactivator 1 | 2 | 2 | ||||||||
MIRT720375 | NUDT3 | nudix hydrolase 3 | 2 | 2 | ||||||||
MIRT723639 | STK25 | serine/threonine kinase 25 | 2 | 2 | ||||||||
MIRT737393 | FOXM1 | forkhead box M1 | 4 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|